Int. Journal of Clinical Pharmacology and Therapeutics, Volume 43 - September (441 - 443)

Interferon-induced pulmonary sarcoidosis
R. Farah, R. Farah, N. Makhoul
1 Department of Internal Medicine F, Western Galilee Hospital, Nahariya, Israel, 2 Leumit Health Service, Western Galilee, Israel, and 3 Intensive Care Unit, Western Galilee Hospital, Nahariya, Israel

Add to Cart  

 

DOI 10.5414/CPP43441

Abstract

A further new case of sarcoidosis associated with the use of interferon (IFN) in the classical treatment of chronic hepatitis C (CHC) is reported. During the last two years, more than 20 cases of interferon-induced sarcoidosis have been described in the literature and about half of these cases have involved CHC. Therefore this disorder appears more common than originally thought two years ago, possibly due to the more frequent use of interferon therapy and an improvement in the methods of diagnosis.

Author Details

Authors

Departments

  • 1 Department of Internal Medicine F, Western Galilee Hospital, Nahariya, Israel,
  • 2 Leumit Health Service, Western Galilee, Israel, and
  • 3 Intensive Care Unit, Western Galilee Hospital, Nahariya, Israel

Address

R. Farah, M.D. Department of Internal Medicine F Western Galilee Hospital P.O.Box 21 Nahariya 22100, Israel
Email: [email protected], [email protected]

Citation

R. Farah, R. Farah and N. Makhoul. Interferon-induced pulmonary sarcoidosis. 2005; 43: 441-443. doi: 10.5414/CPP43441.

###article_not_exists_msg###

Shopping Overview

Shopping Overview
Type Qtty Discount VAT Price
Your basket is empty
View Cart